Wolverine Trading
TEVA icon

Wolverine Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Wolverine Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.17M Sell
217,500
-1,600
-0.7% -$28.1K ﹤0.01% 1528
2025
Q2 		$3.67M Sell
219,100
-20,400
-9% -$329K ﹤0.01% 1261
2025
Q1 		$3.61M Buy
239,500
+61,300
+34% +$1.09M ﹤0.01% 1205
2024
Q4 		$3.98M Buy
178,200
+64,200
+56% +$1.17M ﹤0.01% 1370
2024
Q3 		$1.99M Buy
114,000
+31,000
+37% +$543K ﹤0.01% 1697
2024
Q2 		$1.35M Sell
83,000
-228,000
-73% -$3.51M ﹤0.01% 1912
2024
Q1 		$4.39M Buy
311,000
+41,300
+15% +$521K ﹤0.01% 1087
2023
Q4 		$2.82M Sell
269,700
-145,400
-35% -$1.36M ﹤0.01% 1458
2023
Q3 		$4.23M Buy
415,100
+92,500
+29% +$861K ﹤0.01% 1101
2023
Q2 		$2.44M Sell
322,600
-155,400
-33% -$1.26M ﹤0.01% 1366
2023
Q1 		$4.22M Buy
478,000
+109,600
+30% +$1.08M 0.01% 934
2022
Q4 		$3.36M Buy
368,400
+222,300
+152% +$1.94M 0.01% 1096
2022
Q3 		$1.14M Sell
146,100
-89,400
-38% -$791K ﹤0.01% 1829
2022
Q2 		$1.87M Buy
235,500
+20,400
+9% +$178K ﹤0.01% 1425
2022
Q1 		$2.02M Sell
215,100
-117,400
-35% -$980K ﹤0.01% 1766
2021
Q4 		$2.63M Buy
332,500
+49,300
+17% +$445K ﹤0.01% 1640
2021
Q3 		$2.82M Buy
283,200
+24,300
+9% +$228K ﹤0.01% 1784
2021
Q2 		$2.6M Buy
258,900
+47,200
+22% +$500K ﹤0.01% 1713
2021
Q1 		$2.4M Sell
211,700
-178,100
-46% -$2.04M ﹤0.01% 1767
2020
Q4 		$3.74M Buy
389,800
+55,300
+17% +$530K 0.01% 1271
2020
Q3 		$2.96M Buy
334,500
+19,700
+6% +$208K 0.01% 1178
2020
Q2 		$3.83M Sell
314,800
-272,500
-46% -$3.08M 0.01% 970
2020
Q1 		$5M Sell
587,300
-403,200
-41% -$4.13M 0.02% 760
2019
Q4 		$9.63M Buy
990,500
+723,500
+271% +$6.46M 0.02% 692
2019
Q3 		$1.85M Sell
267,000
-12,800
-5% -$98.1K 0.01% 1490
2019
Q2 		$2.58M Sell
279,800
-68,800
-20% -$830K 0.01% 1324
2019
Q1 		$5.47M Buy
348,600
+9,500
+3% +$168K 0.02% 828
2018
Q4 		$5.32M Sell
339,100
-28,000
-8% -$574K 0.02% 781
2018
Q3 		$7.91M Buy
367,100
+161,700
+79% +$3.75M 0.02% 681
2018
Q2 		$3.51M Hold
205,400
– – 0.01% 1143
2018
Q1 		$3.51M Buy
+205,400
New +$4.01M 0.01% 1143
2017
Q4 		– Sell
-314,400
Closed -$5.53M – 5466
2017
Q3 		$5.53M Buy
314,400
+60,000
+24% +$1.35M 0.02% 712
2017
Q2 		$8.35M Buy
254,400
+17,500
+7% +$542K 0.04% 441
2017
Q1 		$7.75M Sell
236,900
-13,900
-6% -$474K 0.04% 449
2016
Q4 		$9.09M Buy
250,800
+91,500
+57% +$3.65M 0.04% 429
2016
Q3 		$7.37M Sell
159,300
-38,600
-20% -$2.01M 0.03% 559
2016
Q2 		$9.95M Buy
+197,900
New +$10.5M 0.06% 353

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Wolverine Trading's TEVA Position: Q3 2025 in Review

Wolverine Trading increased its Teva Pharmaceuticals (TEVA) stake by 88% in Q3 2025, buying an estimated $1.06M and bringing the position to 128,085 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

Wolverine Trading first reported a position in TEVA in Q2 2016 and has held it in 36 quarters since. The position peaked at $5.27M in Q4 2016. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Wolverine Trading held 128,085 shares of Teva Pharmaceuticals worth $2.46M as of Q3 2025.
  • Wolverine Trading bought 60,109 Teva Pharmaceuticals shares in Q3 2025, an estimated $1.06M.
  • Teva Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2000 holding.
  • Wolverine Trading first reported a position in Teva Pharmaceuticals in Q2 2016 and has held it in 36 quarters since.
  • Wolverine Trading's Teva Pharmaceuticals position peaked at $5.27M in Q4 2016.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.